The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis
Objective: There is currently no effective treatment for Japanese encephalitis, which has a high rate of morbidity and mortality. This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortali...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-11-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.711674/full |
| _version_ | 1818841156270686208 |
|---|---|
| author | Wang Miao Junshuang Guo Shuyu Zhang Nannan Shen Xiaoping Shang Furong Liu Warren Lu Jianghai Xu Junfang Teng |
| author_facet | Wang Miao Junshuang Guo Shuyu Zhang Nannan Shen Xiaoping Shang Furong Liu Warren Lu Jianghai Xu Junfang Teng |
| author_sort | Wang Miao |
| collection | DOAJ |
| description | Objective: There is currently no effective treatment for Japanese encephalitis, which has a high rate of morbidity and mortality. This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis.Methods: We retrospectively assessed the clinical data of 31 patients diagnosed with Japanese encephalitis, who were admitted to an intensive care unit. Patients were divided into the TAGMIC and non-TAGMIC group according to their treatment regime. We compared the 60-day, 6-month, and overall mortality and survival curves between groups. We also compared Barthel Index scores, Montreal Cognitive Assessment (MoCA) scores, and diffusion tensor imaging (DTI) results.Results: There was no significant difference in the 30-day mortality rate or Kaplan–Meier survival curve between groups. The 60-day, 6-month, and overall mortality rates in the TAGMIC group were significantly reduced (P = 0.043, P = 0.018, and P = 0.018, respectively) compared with the non-TAGMIC group (0, 0, 0 vs. 31.25, 37.5, 37.5%, respectively). The 60-day, 6-month, and overall Kaplan–Meier survival curves were significantly different between groups (P = 0.020, P = 0.009, P = 0.009, respectively). There was no significant difference in the Barthel Index scores of surviving patients. Among the five patients who underwent MoCA and DTI, four had a score of 0/5 for delayed recall (no cue), while the remaining patient had a score of 2/5. All five patients were able to achieve a score of 5/5 with classification and multiple-choice prompts, and had sparse or broken corpus callosum (or other) fibre bundles.Conclusion: TAGMIC treatment can reduce mortality due to severe Japanese encephalitis. The memory loss of surviving patients is mainly due to a disorder of the memory retrieval process, which may be related to the breakage of related fibre bundles. |
| first_indexed | 2024-12-19T04:21:36Z |
| format | Article |
| id | doaj.art-f9c08e01931642a5b225549c33b34aa4 |
| institution | Directory Open Access Journal |
| issn | 1664-2295 |
| language | English |
| last_indexed | 2024-12-19T04:21:36Z |
| publishDate | 2021-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj.art-f9c08e01931642a5b225549c33b34aa42022-12-21T20:36:09ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-11-011210.3389/fneur.2021.711674711674The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese EncephalitisWang Miao0Junshuang Guo1Shuyu Zhang2Nannan Shen3Xiaoping Shang4Furong Liu5Warren Lu6Jianghai Xu7Junfang Teng8Neuro-Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaNeuro-Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaNeuro-Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaNeuro-Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Medical Records Management, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Medical Records Management, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Biology, New York University, New York, NY, United StatesThird Department of Infectious Diseases, Anyang Fifth People's Hospital, Anyang, ChinaNeuro-Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaObjective: There is currently no effective treatment for Japanese encephalitis, which has a high rate of morbidity and mortality. This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis.Methods: We retrospectively assessed the clinical data of 31 patients diagnosed with Japanese encephalitis, who were admitted to an intensive care unit. Patients were divided into the TAGMIC and non-TAGMIC group according to their treatment regime. We compared the 60-day, 6-month, and overall mortality and survival curves between groups. We also compared Barthel Index scores, Montreal Cognitive Assessment (MoCA) scores, and diffusion tensor imaging (DTI) results.Results: There was no significant difference in the 30-day mortality rate or Kaplan–Meier survival curve between groups. The 60-day, 6-month, and overall mortality rates in the TAGMIC group were significantly reduced (P = 0.043, P = 0.018, and P = 0.018, respectively) compared with the non-TAGMIC group (0, 0, 0 vs. 31.25, 37.5, 37.5%, respectively). The 60-day, 6-month, and overall Kaplan–Meier survival curves were significantly different between groups (P = 0.020, P = 0.009, P = 0.009, respectively). There was no significant difference in the Barthel Index scores of surviving patients. Among the five patients who underwent MoCA and DTI, four had a score of 0/5 for delayed recall (no cue), while the remaining patient had a score of 2/5. All five patients were able to achieve a score of 5/5 with classification and multiple-choice prompts, and had sparse or broken corpus callosum (or other) fibre bundles.Conclusion: TAGMIC treatment can reduce mortality due to severe Japanese encephalitis. The memory loss of surviving patients is mainly due to a disorder of the memory retrieval process, which may be related to the breakage of related fibre bundles.https://www.frontiersin.org/articles/10.3389/fneur.2021.711674/fullganciclovirmethylprednisoloneimmunoglobulinJapanese encephalitiscombined regimen |
| spellingShingle | Wang Miao Junshuang Guo Shuyu Zhang Nannan Shen Xiaoping Shang Furong Liu Warren Lu Jianghai Xu Junfang Teng The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis Frontiers in Neurology ganciclovir methylprednisolone immunoglobulin Japanese encephalitis combined regimen |
| title | The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis |
| title_full | The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis |
| title_fullStr | The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis |
| title_full_unstemmed | The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis |
| title_short | The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis |
| title_sort | effect of a combined ganciclovir methylprednisolone and immunoglobulin regimen on survival and functional outcomes in patients with japanese encephalitis |
| topic | ganciclovir methylprednisolone immunoglobulin Japanese encephalitis combined regimen |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2021.711674/full |
| work_keys_str_mv | AT wangmiao theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT junshuangguo theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT shuyuzhang theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT nannanshen theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT xiaopingshang theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT furongliu theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT warrenlu theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT jianghaixu theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT junfangteng theeffectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT wangmiao effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT junshuangguo effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT shuyuzhang effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT nannanshen effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT xiaopingshang effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT furongliu effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT warrenlu effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT jianghaixu effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis AT junfangteng effectofacombinedganciclovirmethylprednisoloneandimmunoglobulinregimenonsurvivalandfunctionaloutcomesinpatientswithjapaneseencephalitis |